Amy N. Allen - Concepedia

Author

Amy N. Allen

Johns Hopkins University ORCID

Also Known As

A. Allen, Allen, Allyssa Jane, Amy Allen, Amy N Allen, Amy N. Allen

Publications

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Medicine Memorial Sloan Kettering Cancer Center National Institutes of Health

About

Amy N. Allen is an author at Johns Hopkins University specializing in cell biology, medicine, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	455
2	Cell Biology	2	2	455
3	Immunology	1	1	439
4	Pathology	1	1	16
5	Autoimmunity	1	1	439

Amy N. Allen

Publications

Citations

H-Index

Page 1

	Year	Citations
Egr-2 and Egr-3 are negative regulators of T cell activation M. Safford, Samuel L. Collins, Michael A. Lutz, Nature Immunology T Cell ActivationSignal TransductionCell RegulationT-regulatory CellImmunology	2005	439
A Role for Mammalian Target of Rapamycin in Regulating T Cell Activation versus Anergy Yan Zheng, Samuel L. Collins, Michael A. Lutz, The Journal of Immunology	2007	271
A Secondary Mutation in <i>BRAF</i> Confers Resistance to RAF Inhibition in a <i>BRAF</i> V600E-Mutant Brain Tumor Jiawan Wang, Zhan Yao, Philip Jonsson, Cancer Discovery	2018	68
Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors Jiawan Wang, Kai Pollard, Amy N. Allen, Cancer Research	2020	62
The Novel Cyclophilin Binding Compound, Sanglifehrin A, Disassociates G1 Cell Cycle Arrest from Tolerance Induction Amy N. Allen, Yan Zheng, Lawrence B. Gardner, The Journal of Immunology	2004	46
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma Patience Odeniyide, Marielle E. Yohe, Kai Pollard, Oncogene	2022	41
Combination MEK and mTOR inhibitor therapy is active in models of glioblastoma Karisa C. Schreck, Amy N. Allen, Jiawan Wang, Neuro-Oncology Advances	2020	37
Association of Race Consciousness With the Patient-Physician Relationship, Medication Adherence, and Blood Pressure in Urban Primary Care Patients LaPrincess C. Brewer, Kathryn A. Carson, D. R. Williams, American Journal of Hypertension	2013	33
Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition Amy N. Allen, Alice Can Ran Qin, Nitya Raj, PLoS ONE Braf-mutated PannetPathologyBraf AlterationsTumor BiologyPancreatic Cancer	2019	16

Page 1